Stories of Drug Discovery Success 

Event Description

Join us for an insightful morning of conversation exploring what it really takes to turn visionary science into the next generation of therapeutics.

Hosted by Sygnature Discovery, this fireside chat will bring together biotech leaders to share the real stories behind company creation, scientific discovery and the journey from an initial idea to a drug candidate. We’ll explore the breakthroughs, challenges and pivotal decisions that shape successful programs, from choosing the right biology and building high-performing teams to navigating fundraising and making every investment count.

Our speakers will share how they are tackling today’s scientific and financial pressures, balancing cost, quality and speed, and using strategic CRO partnerships not simply to generate data, but to bring additional scientific thinking, challenge assumptions, reduce risk and accelerate programs.

 

What to Expect 

  • Candid insights into the discoveries they’re championing, the lessons learned along the way, and their vision for what comes next.
  • Come for the science. Stay for the stories, connections and conversations shaping the future of drug discovery.

Event Details 

Date: Thursday 24th September
Time: 08:00 - 12:00 (CEST)
Location:  Nobel Conference Room (4th Floor), Forskaren, Hagastaden, Stockholm. 
Access: By invitation only (please fill the form)

 

Agenda

  • 8:00 - Doors Open, Networking, Registration & Breakfast

  • 9:00 - Welcome & Introduction
    Dan O'Flynn, Sygnature Discovery

  • 9:15 - Biotech Presentations
    Martin Andersson, Co-founder & CSO, Sprint Bioscience
    Alina Castell, Founder & CEO, MyCural Therapeutics
    Michael-Robin Witt, CEO, Gabather

  • 10:00 - Break

  • 10:15 -Storm Therapeutics Case Study
    Allan Jordan, VP Oncology Drug Discovery, Sygnature Discovery 

  • 10:45 - Fireside Chat: "Stories of Biotech Science, Strategy, and Success" 
    Martin Andersson, Co-founder & CSO, Sprint Bioscience
    Alina Castell, Founder & CEO, MyCural Therapeutics
    Michael-Robin Witt, CEO, Gabather
    Moderated by Allan Jordan

  • 11:45 - Lunch, Networking & Close

  • 12:00 - End of Meeting

Fireside Chat Focus 

 Integrated drug discovery: what can we learn from real-world stories of science and success...?

Save your spot!